PA Lookup
If you have questions about prior authorizations, please call:
Member and Recipient Service Line: 1-877-685-2415
Provider Support Service Line: 1-855-250-1539
Removal of implanted material, posterior segment; extraocular
How to Submit
N/A - No authorization is required
Removal of implanted material, posterior segment; intraocular
How to Submit
N/A - No authorization is required
Prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage, 1 or more sessions; cryotherapy, diathermy
How to Submit
N/A - No authorization is required
Prophylaxis of retinal detachment (eg, retinal break, lattice degeneration) without drainage, 1 or more sessions; photocoagulation (laser or xenon arc)
How to Submit
N/A - No authorization is required
Destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; cryotherapy, diathermy
How to Submit
N/A - No authorization is required
Destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; photocoagulation
How to Submit
N/A - No authorization is required
Destruction of localized lesion of retina (eg, macular edema, tumors), 1 or more sessions; radiation by implantation of source (includes removal of source)
How to Submit
N/A - No authorization is required
Destruction of localized lesion of choroid (eg, choroidal neovascularization); photocoagulation (eg, laser), 1 or more sessions
How to Submit
N/A - No authorization is required
Ocular Photodynamic Therapy
Ocular photodynamic therapy (OPT) is a treatment approved by the Food and Drug Administration for age-related macular degeneration (AMD), pathologic myopia, and ocular histoplasmosis. OPT is a two-step procedure involving the intravenous injection verteporfin (Visudyne®), a photosensitive drug. After injection, the verteporfin is activated by illumination with a non-thermal laser light at the wavelength that corresponds to the absorption peak of the drug. The light reacts with the photosensitive chemical in verteporfin, and the abnormal vessels are destroyed with no damage to the normal ones.
Limits
Beneficiaries may receive up to five treatments per eye per year with a maximum of ten treatments per eye during a 2-year-period.
Separate reimbursement is not allowed for intravenous infusion services.
Providers must maintain documentation including fluorescein angiogram and submit to NC Medicaid or its fiscal agent upon request.
Place of Service
Inpatient, Outpatient, Office
How to Submit
N/A - No authorization is required
Resources
Ocular Photodynamic Therapy
Ocular photodynamic therapy (OPT) is a treatment approved by the Food and Drug Administration for age-related macular degeneration (AMD), pathologic myopia, and ocular histoplasmosis. OPT is a two-step procedure involving the intravenous injection verteporfin (Visudyne®), a photosensitive drug. After injection, the verteporfin is activated by illumination with a non-thermal laser light at the wavelength that corresponds to the absorption peak of the drug. The light reacts with the photosensitive chemical in verteporfin, and the abnormal vessels are destroyed with no damage to the normal ones.
Limits
Beneficiaries may receive up to five treatments per eye per year with a maximum of ten treatments per eye during a 2-year-period.
Separate reimbursement is not allowed for intravenous infusion services.
Providers must maintain documentation including fluorescein angiogram and submit to NC Medicaid or its fiscal agent upon request.
Place of Service
Inpatient, Outpatient, Office
How to Submit
N/A - No authorization is required
Resources
Destruction of extensive or progressive retinopathy (eg, diabetic retinopathy), cryotherapy, diathermy
How to Submit
N/A - No authorization is required
Treatment of extensive or progressive retinopathy (eg, diabetic retinopathy), photocoagulation
How to Submit
N/A - No authorization is required
Treatment of extensive or progressive retinopathy, 1 or more sessions, preterm infant (less than 37 weeks gestation at birth), performed from birth up to 1 year of age (eg, retinopathy of prematurity), photocoagulation or cryotherapy
How to Submit
N/A - No authorization is required
Scleral reinforcement (separate procedure); without graft
How to Submit
N/A - No authorization is required
Scleral reinforcement (separate procedure); with graft
How to Submit
N/A - No authorization is required
Unlisted procedure, posterior segment
Authorization Guidelines
Please submit any records and any other information that you believe support the member has met the applicable medical necessity criteria to Trillium.
How to Submit
Please submit your request to Trillium Health Resources
Strabismus surgery, recession or resection procedure; 1 horizontal muscle
How to Submit
N/A - No authorization is required
Strabismus surgery, recession or resection procedure; 2 horizontal muscles
How to Submit
N/A - No authorization is required
Strabismus surgery, recession or resection procedure; 1 vertical muscle (excluding superior oblique)
How to Submit
N/A - No authorization is required
Strabismus surgery, recession or resection procedure; 2 or more vertical muscles (excluding superior oblique)
How to Submit
N/A - No authorization is required
If you find any wrong or out of date information on our pages, we want to know. Please email info@TrilliumNC.org with any corrections.